The first person in the US to be treated for sickle cell disease with a CRISPR-based gene therapy is approaching the one-year anniversary of her treatment, which appears to be effective and durable. The treatment also appears effective in two patients with beta thalassemia, researchers say.
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.